Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Soluble urokinase plasminogen activator receptor and functionally relevant coronary artery disease: a prospective cohort study

Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  • Joan Elias Walter
  • Melissa Lee Fen Amrein
  • Ibrahim Schäfer
  • Tobias Zimmermann
  • Pedro Lopez-Ayala
  • Jasper Boeddinghaus
  • Raphael Twerenbold
  • Christian Puelacher
  • Thomas Nestelberger
  • Desiree Wussler
  • Ursina Honegger
  • Patrick Badertscher
  • Jesper Eugen-Olsen
  • Luca Koechlin
  • Gregor Fahrni
  • Raban Jeger
  • Christoph Kaiser
  • Michael Zellweger
  • Christian Mueller
Vis graf over relationer

BACKGROUND: Soluble urokinase plasminogen activator receptor (suPAR) is an emerging biomarker associated with anatomical CAD burden and cardiovascular outcomes including myocardial infarction (MI) and death. We aimed to validate previous findings of the prognostic value of suPAR and to evaluate its diagnostic potential for functional relevant CAD (fCAD).

METHODS: Consecutive patients with suspected fCAD were enrolled. Adjudication of fCAD was performed blinded to suPAR concentrations by myocardial perfusion single-photon emission tomography (MPI-SPECT) and coronary angiography. Prognostic outcome measures included all-cause death, cardiovascular death, and incident MI during 2-year follow-up.

RESULTS: Among consecutive 968 patients, suPAR concentrations were higher in patients with fCAD compared to those without (3.45 vs. 3.20 ng/mL, p = 0.007), but did not provide acceptable diagnostic accuracy (area under the curve [AUC]: 0.56, 95%CI 0.52-0.60). SuPAR correlated with high-sensitivity cardiac-troponin T (Spearman's rho (ρ) 0.393, p < 0.001), NT-proBNP (ρ = 0.327, p < 0.001), age (ρ = 0.364, p < 0.001) and very weakly with coronary atherosclerosis (ρ = 0.123, p < 0.001). Prognostic discrimination of suPAR was moderate for cardiovascular death (AUC = 0.72, 95%CI 0.62-0.81) and all-cause death (AUC = 0.72, 95%CI 0.65-0.79) at 2-years. SuPAR remained a significant predictor for all-cause death in multivariable Cox regression (HR = 1.96, p = 0.001).

CONCLUSIONS: SuPAR was an independent predictor of all-cause death, without diagnostic utility for fCAD.

CLINICAL TRIAL REGISTRATION: NCT01838148.

OriginalsprogEngelsk
Artikelnummer2038269
TidsskriftBiomarkers
Vol/bind27
Udgave nummer3
Sider (fra-til)278-285
Antal sider8
ISSN1354-750X
DOI
StatusUdgivet - maj 2022

ID: 73538430